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Abstract
Cancer of the salivary gland is one of the common cancers in the head and the neck regions. This type of cancer 
develops in the minor and the major salivary glands, and it sometimes metastasizes to other organs, particularly 
the lung. Morphologic mimicry and similarity in the expression of steroid hormone receptors between salivary 
gland tumors and breast tumors are well-known phenomena and are occasionally debated in the field of surgical 
pathology. The expression of sex hormone receptors in some tumors suggests a role for these receptors in tumor 
pathogenesis and therapy. Previous studies of the expression of estrogens and progesterone receptors in salivary 
gland tumors have reported conflicting results. 
Objective: Our study aimed to characterize alteration in the immunohistochemical expression of estrogens recep-
tor and progesterone receptor in the tumor cells of carcinoma arising in pleomorphic adenoma. Study design: 27 
cases of carcinoma arising in pleomorphic adenoma (undifferentiated and adenocarcinoma types) were exami-
ned. 
Results: The results showed that 27 (100 %) of 27 cases had negative nuclear staining for either estrogens or pro-
gesterone receptors. 
Conclusion: Our data suggest that carcinomas arising in pleomorphic adenoma were not dependent on endocrine 
function.
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Introduction
Salivary gland carcinomas account for 0.4 % of all can-
cers and 5 % of all head and neck malignancies (1). The 
use of molecular biology technique has aided in study-
ing such these tumors (2). Although some salivary gland 
tumors are benign, but they have shown metastasis (3), 
therefore, those tumors are very dangerous. Salivary 
gland carcinomas are histologically similar to certain 
types of breast carcinoma (4). The discovery of hor-
monal receptors facilitated the identification of breast 
cancer patients who can get the benefit from hormone 
therapy (5). Immunocytochemical techniques have 
shown nuclear distribution of estrogens and progeste-
rone receptors in carcinoma of breast cells and benign 
lobular or ductal epithelial cells, with no specific stai-
ning seen in the surrounding connective tissue. Immu-
nocytochemistry of estrogens receptor has been shown 
to predict response of breast cancer to endocrine the-
rapy (6-7).  Previous studies (8-12) reported that some 
tumors other than breast cancer have hormone receptors 
e.g melanoma, carcinoid tumors, pancreatic, and renal 
cancers. It is unknown whether salivary gland cancers 
are hormone dependent or independent. The purpose of 
this study was to determine, with the use of immuno-
histochemistry, if Estrogens receptor and progesterone 
receptor can be identified in formalin- fixed paraffin 
embedded tumor cells of carcinoma arising in pleomor-
phic adenoma. 
Materials and Methods 
The proposed criteria for defining carcinoma ex-pleo-
morphic adenoma by Nagao et al. (13) were used to se-
lect and reclassify our cases of carcinoma ex-pleomor-
phic adenoma.
The use of strict pathological criteria may underesti-
mate the frequency of carcinoma ex pleomorphic ad-
enoma because the malignant cells in some cases may 
obliterate the original pleomorphic adenoma. 
Inclusion criteria for carcinoma ex-pleomorphic ade-
noma
• Major gland primary lesion (parotid or submandibu-
lar)
• Co-existent benign and malignant elements benign ele-
ment can be:
• Pleomorphic adenoma within the tumor mass
• Biopsy proven history of previous PSA (pleomorphic 
salivary adenoma) indicated that it was in the same 
location as the subsequent carcinoma. Malignant ele-
ments can be:
• Undifferentiated carcinoma
• Adenocarcinoma
• Multiple patterns of differentiation including undif-
ferentiated or adenocarcinoma patterns
Exclusion criteria for carcinoma ex-pleomorphic ad-
enoma includes any other type of tumor.
Twenty seven cases of carcinoma arising in pleomor-
phic adenoma were included in this study. Immunostai-
ning techniques were applied to localize the estrogens 
and progesterone receptors in the tissues. 
Nuclear staining of estrogen and progesterone recep-
tors was considered only as a positive result indicating 
presence of receptor proteins. Two independent exam-
iners scored the sections for the presence of estrogens 
and progesterone receptors. Following examination the 
entire section, five random areas were chosen from each 
slide. The scoring criteria was considered two catego-
ries: positive or negative nuclear staining. Estrogens 
receptor or progesterone receptor positive nuclei was 
assessed by two independent observers and scored as: 
as negative is <75% staining and positive as greater than 
75% of cells. 
The local NHS Research Ethics Committee provided a 
favorable ethical opinion (Ref: 02/104).
Tissue blocks of breast carcinoma with normal sur-
rounding tissue, of known positive (five specimens) and 
negative (five specimens) estrogens and progesterone 
receptors status were used as positive controls.
Immunhistochemistry 
Paraffin-embedded, 4-µm-thick tissue sections from 
all 27 specimens were cut. The sections were deparaffi-
nized in xylene and rehydrated through graded alco-
hols. Sections were processed used streptavidin-biotin-
peroxidase method. Briefly, the endogenous peroxidase 
was blocked by 3 % hydrogen peroxidase for 5 min 
followed by TBS wash. Non specific immunoreactivi-
ty was blocked by incubation with normal goat serum 
for 20 minutes. Dako mouse anti-human Estrogens re-
ceptor OR 1D5 was diluted to 1: 25 (40 µL /ml) in tris 
buffer saline (TSA) containing 0.1 % bovine serum al-
bumin for 10 minutes at the room temperature. Dako 
mouse anti-human progesterone receptor PR 636 was 
diluted to 10 µ/ml in tris buffer saline (TSA) containing 
0.1 % bovine serum albumin for 10 minutes at the room 
temperature. All sections were washed by TBS for 5 
minutes. Sections were incubated with the biotinylated 
secondary antibody reagent for 10 minutes followed by 
(TBS) wash for 5 minutes. Slides were incubated with 
streptavidin and horseradish peroxidase for 10 minutes 
followed by (TBS) tris buffer saline wash for 5 minutes. 
Incubate with a prepared chromogenic substrate solu-
tion (Diaminobenizidine) for 15 minutes. Sections were 
counterstained with 0.25 % methyl green in distilled 
water for 5 minutes. Sections were dehydrated and 
mounted in Depax. Breast cancer was used as positive 
control. Negative control was used only with substitu-
tion the primary antibody with TBS. 
Statistical analysis
The data were described using frequency distribution.
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Results
The results showed that 27 (100 %) of 27 cases had 
negative nuclear staining for either estrogens or proges-
terone receptors. 17 cases out of 27 (63%) showed estro-
gens positive cytoplasmic staining but 10 cases out of 
27 (37%) showed estrogens negative cytoplasam stain-
ing. 5 cases out of 27 (18.5%) showed progesterone posi-
tive cytoplasam staining but 22 cases out of 27 (81.5%) 
showed progesterone negative cytoplasam staining. The 
positive nuclear staining (positive control) from breast 
cancer of the estrogens and progesterone receptors, and 
negative nuclear staining for either estrogens or proges-
terone receptors in carcinoma arising in pleomorphic 
adenoma are shown in (Fig. 1-4). The Clinical hit-
Fig. 1. Showing negative nuclear and weak positive cytoplasmic 
staining of Carcinoma ex pleomorphic adenoma for progestero-
ne receptor. Original magnification x40.
Fig. 2. Showing negative nuclear staining of Carcinoma ex pleomor-
phic adenoma for oestrogen receptor. Original magnification x40.
Fig. 4. Showing positive nuclear staining of oestrogen recep-
tor in normal breast tissue surrounding a carcinoma. Original 
magnification x40.
Fig. 3. Showing positive nuclear staining of progesterone re-
ceptor in normal breast tissue surrounding a carcinoma. Origi-
nal magnification x40.




sopathological and immunohistochemical characteriza-
tion of estrogens and progesterone receptors in carcino-
mas ex-pleomorphic adenomas are shown in (Table 1).
Discussion
The assessment of the positive or negative nuclear 
staining cells is controversial. Many authors (14-16) 
used different criteria e.g (0=negative staining, 1=low, 
2=moderate, 3=strong or 0-3=negative and 4=positive 
or 0-2=negative and 3-4=positive or negative and posi-
tive staining) so the results cannot be compared, there-
fore, we have used a strict criteria to assess the negative 
and positive staining to avoid any confusion in the in-
terpretation of the results. The rational of 75% break po-
int may provide a more complete assessment of protein 
expression and a clearer understanding of the roles pla-
yed by potential tumour markers in predicting outcome.
Estrogens and progesterone nuclear staining were not 
detected in our cases of carcinoma arising in pleomor-
phic adenoma. This is the first study to assess the pre-
sence of progesterone and estrogens receptors in carci-
noma arising in pleomorphic adenoma. Dimery et al. (8) 
detected 15 of 19 (79%) cases of normal salivary gland 
tissue and 3 out of four adenoid cystic carcinomas to be 
estrogens receptor positive, but their study used a less 
specific filtration assay of estradiol titration on pulve-
rized fresh frozen tissue in which stromal components 
such as fibrous tissue and blood vessels were included. 
These stromal tissues can bind tritiated estradiol, thus 
providing false positive results. In the present study im-
munohistochemical staining was used which allows di-
rect visualization of positive cells. The results are con-
sistent with those of Shick et al. (17) who found no estro-
gens receptor in their cases of adenoid cystic carcinoma. 
Dori et al. (18) found 2 cases with progesterone positive 
staining out of 27 adenoid cystic carcinoma but estro-
gens receptor was negatively expressed in all cases. Mi-
ller et al. (19) found the estrogens receptor was absent in 
their cases of polymorphous low-grade adenocarcinoma 
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and adenoid cystic carcinoma of salivary gland origin. 
Nasser et al. (20) have indicated that estrogens and pro-
gesterone receptors were expressed in only a few cases 
of salivary gland tumors. The difference in the results 
with the present study might be due to various factors: 
gender, age, specific tumour histology, immunohisto-
chemical technique and the pathological interpretation 
of the staining due to a lack of strict evaluation criteria. 
Conclusion
The results suggested that carcinomas arising in pleo-
morphic adenoma were not dependent on endocrine 
function. The study included 27 cases of carcinoma aris-
ing in pleomorphic adenoma, which was a large sample 
compared with many other studies. It is recommended 
that further work involves a large series of carcinoma 
arising in pleomorphic adenoma to determine if estro-
gens and progesterone receptors using sensitive and 
specific biochemical methods can be detected in those 
tumors. Other receptors, such as EGF for which thera-
peutic drugs are available could also be examined.
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